{"id":"NCT00003901","sponsor":"Alliance for Clinical Trials in Oncology","briefTitle":"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery","officialTitle":"A Prospective Study of the Prognostic Significance of Occult Metastases in the Patient With Resectable Non-Small Cell Lung Carcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1999-07","primaryCompletion":"2011-10","completion":"2011-10","firstPosted":"2003-01-27","resultsPosted":"2017-02-16","lastUpdate":"2017-02-16"},"enrollment":1310,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Lung Cancer"],"interventions":[{"type":"OTHER","name":"immunohistochemistry staining method","otherNames":[]},{"type":"PROCEDURE","name":"biopsy","otherNames":[]},{"type":"PROCEDURE","name":"surgery","otherNames":[]}],"arms":[{"label":"Surgery","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment.\n\nPURPOSE: Phase III trial to study the relationship between early signs of metastases and survival in patients who have stage I, stage II, or stage III non-small cell lung cancer that can be removed by surgery.","primaryOutcome":{"measure":"Overall Survival in Lymph Nodes Examined Patients","timeFrame":"Up to 5 years","effectByArm":[{"arm":"OM Negative in Lymph Nodes","deltaMin":null,"sd":null},{"arm":"OM Positive in Lymph Nodes","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":58,"countries":["United States","Canada"]},"refs":{"pmids":["21990404"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}